These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38406259)

  • 21. Combination of Oral Anticoagulants and Single Antiplatelets versus Triple Therapy in Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome: Stroke Prevention among Asians.
    Santoso A; Raharjo SB
    Int J Angiol; 2020 Jun; 29(2):88-97. PubMed ID: 32499669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk.
    Verbrugge FH; Martin AC; Siegal D; Pieper K; Illingworth L; Camm AJ; Fox KAA
    Heart; 2020 Jun; 106(11):845-851. PubMed ID: 31806700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry.
    Márquez MF; Baños-González MA; Guevara-Valdivia ME; Vázquez-Acosta J; de Los Ríos Ibarra MO; Aguilar-Linares JA; Jiménez-Cruz M; Matadamas-Hernández N; Camacho-Casillas R; Magaña-Magaña R; Rojel-Martínez U; Alcocer-Gamba MA; Lara-Vaca S; Rodríguez-Reyes H; Islava-Gálvez MA; Betancourt-Hernández LE; Reyes-Reyes N; Beltrán-Gámez ME; Cantú-Brito C; Baños-Velasco AZ; Del Rivero Morfin PJ; González-Hermosillo JA
    Glob Heart; 2020 Apr; 15(1):32. PubMed ID: 32489805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anticoagulation in octogenarians with atrial fibrillation.
    Hugo GS; Figueiras-Graillet LM; Anguita M; Marín F; Bertomeu V; Roldán I; Ruiz M; Muñiz J; Martínez-Sellés M;
    Int J Cardiol; 2016 Nov; 223():87-90. PubMed ID: 27532238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
    Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
    Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry.
    Park H; Yu HT; Kim TH; Park J; Park JK; Kang KW; Shim J; Kim JB; Kim J; Choi EK; Park HW; Lee YS; Joung B
    Yonsei Med J; 2023 Jan; 64(1):18-24. PubMed ID: 36579375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary stroke prophylaxis in atrial fibrillation patients with chronic kidney disease: a nationwide cohort study.
    Christensen MA; Fosbøl EL; Bonde AN; Olesen JB; Gislason GH; Torp-Pedersen C; Gundlund A
    Europace; 2020 May; 22(5):716-723. PubMed ID: 31872246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
    Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Ma CS; Zint K; Elsaesser A; Bartels DB; Lip GY;
    J Am Coll Cardiol; 2017 Feb; 69(7):777-785. PubMed ID: 28209218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF).
    Kim H; Lee YS; Kim TH; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Shim J; Uhm JS; Park HW; Choi EK; Kim JB; Kim C; Kim J; Joung B
    Korean J Intern Med; 2020 Jan; 35(1):99-108. PubMed ID: 31014064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation.
    Campos-Staffico AM; Jacoby JP; Dorsch MP; Limdi NA; Barnes GD; Luzum JA
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102285. PubMed ID: 38292348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease.
    Ballegaard ELF; Olesen JB; Kamper AL; Feldt-Rasmussen B; Gislason G; Torp-Pedersen C; Carlson N
    Res Pract Thromb Haemost; 2024 Feb; 8(2):102350. PubMed ID: 38481950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease.
    Budnik M; Gawałko M; Gorczyca I; Uziębło-Życzkowska B; Krzesiński P; Kochanowski J; Scisło P; Michalska A; Jelonek O; Starzyk K; Jurek A; Kiliszek M; Wożakowska-Kapłon B; Gielerak G; Filipiak KJ; Opolski G; Kapłon-Cieślicka A
    Cardiol J; 2022; 29(2):205-215. PubMed ID: 32207840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
    Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
    J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.